PDCD1 and hepatocellular carcinoma: Correlation analysis identified a subset of 10 genes from the 40-gene list that are coherently expressed across the HCC tumors (Fig. 6A), which was independent from the previously published IFN-γ–related tumor inflammation signature (TIS) associated with clinical benefit from anti–PD-1 treatment (48).